Tooth Autotransplantation and Bone Dimension Changes
1 other identifier
interventional
20
1 country
1
Brief Summary
Tooth autotransplantation is a treatment option to replace tooth with imposible prognosis. In several cases the receipt site has a reduced bone dimension. This situation may be imposible the treatment with dental implants without bone reconstruction. Autotransplantation seem to improve the anatomic characteristic of the receipt site without any reconstruction approach. The aim of this study is to evaluate the bone dimension changes followed autotransplantation treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2018
CompletedFirst Submitted
Initial submission to the registry
April 20, 2019
CompletedFirst Posted
Study publicly available on registry
April 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedApril 25, 2019
April 1, 2019
1.1 years
April 20, 2019
April 23, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in alveolar bone 12 months after tooth autotransplantation
CT-scan evaluation before surgery and 1 year after, measuring the difference in millimeters
1 year
Study Arms (1)
AUTOTRANSPLANTATION TOOTH
EXPERIMENTALInterventions
Tooth with imposible prognosis is replace with a healthy tooth from the same patient.
Eligibility Criteria
You may qualify if:
- Tooth with imposible prognosis
- Plaque index score less than 30%
- No relevant systemic disease
- Smokers (Less than 20 cigars/day)
You may not qualify if:
- Pregnancy-Lactation
- Relevant systemic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Murcia
Murcia, 30003, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
April 20, 2019
First Posted
April 25, 2019
Study Start
December 5, 2018
Primary Completion
December 30, 2019
Study Completion
June 30, 2020
Last Updated
April 25, 2019
Record last verified: 2019-04